These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 10882338)

  • 1. Responses to eating: lipoproteins, lipolytic products and atherosclerosis.
    Goldberg IJ; Kako Y; Lutz EP
    Curr Opin Lipidol; 2000 Jun; 11(3):235-41. PubMed ID: 10882338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postprandial lipemia and cardiovascular disease.
    Hyson D; Rutledge JC; Berglund L
    Curr Atheroscler Rep; 2003 Nov; 5(6):437-44. PubMed ID: 14525676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postprandial lipoproteins and atherosclerosis.
    Yu KC; Cooper AD
    Front Biosci; 2001 Mar; 6():D332-54. PubMed ID: 11229885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disturbances in dietary fat metabolism and their role in the development of atherosclerosis.
    Weintraub M; Charach G; Grosskopf I
    Biomed Pharmacother; 1997; 51(8):311-3. PubMed ID: 9436521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis.
    Santamarina-Fojo S; Haudenschild C; Amar M
    Curr Opin Lipidol; 1998 Jun; 9(3):211-9. PubMed ID: 9645503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel aspects of postprandial lipemia in relation to atherosclerosis.
    Alipour A; Elte JW; van Zaanen HC; Rietveld AP; Castro Cabezas M
    Atheroscler Suppl; 2008 Sep; 9(2):39-44. PubMed ID: 18595782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine Treatment for Hypertension is Associated with Enhanced Lipolytic Activity and Accelerated Clearance of Postprandial Lipemia.
    Grosskopf I; Shaish A; Charach G; Harats D; Kamari Y
    Horm Metab Res; 2016 Apr; 48(4):257-62. PubMed ID: 26849821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary cholesterol, cholesterol absorption, postprandial lipemia and atherosclerosis.
    Huff MW
    Can J Clin Pharmacol; 2003; 10 Suppl A():26A-32A. PubMed ID: 14571303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe defect in clearing postprandial chylomicron remnants in dialysis patients.
    Weintraub M; Burstein A; Rassin T; Liron M; Ringel Y; Cabili S; Blum M; Peer G; Iaina A
    Kidney Int; 1992 Nov; 42(5):1247-52. PubMed ID: 1453610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postprandial lipemia as an atherosclerotic risk factor and fat tolerance test].
    Ishikawa T
    Nihon Rinsho; 1999 Dec; 57(12):2668-72. PubMed ID: 10638194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial lipoprotein metabolism and atherosclerosis.
    Karpe F
    J Intern Med; 1999 Oct; 246(4):341-55. PubMed ID: 10583705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer.
    Santamarina-Fojo S; Haudenschild C
    Int J Tissue React; 2000; 22(2-3):39-47. PubMed ID: 10937353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis.
    Hennig B; Toborek M; McClain CJ
    J Am Coll Nutr; 2001 Apr; 20(2 Suppl):97-105. PubMed ID: 11349944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octogenarian subjects have low postprandial levels of chylomicron remnants: a possible explanation for protection against atherosclerosis.
    Weintraub M; Ringel Y; Rassin T; Arad J; Bodner G; Liron M
    J Gerontol; 1992 Nov; 47(6):B209-13. PubMed ID: 1430850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial function and postprandial lipemia.
    Vigna GB; Delli Gatti C; Fellin R
    Nutr Metab Cardiovasc Dis; 2004 Jun; 14(3):121-7. PubMed ID: 15330270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial lipemia and remnant lipoproteins.
    Cohn JS
    Clin Lab Med; 2006 Dec; 26(4):773-86. PubMed ID: 17110239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The postprandial situation as a pro-inflammatory condition.
    de Vries MA; Klop B; Eskes SA; van der Loos TL; Klessens-Godfroy FJ; Wiebolt J; Janssen HW; Westerman EM; Castro Cabezas M
    Clin Investig Arterioscler; 2014; 26(4):184-92. PubMed ID: 24866730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postprandial lipoprotein metabolism and atherosclerosis.
    Karpe F; Hamsten A
    Curr Opin Lipidol; 1995 Jun; 6(3):123-9. PubMed ID: 7648000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of remnants of triglyceride-rich lipoproteins: an atherogenic insult?
    Chung BH; Segrest JP
    Adv Exp Med Biol; 1991; 285():341-51. PubMed ID: 1858566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postprandial enrichment of remnant lipoproteins with apoC-I in healthy normolipidemic men with early asymptomatic atherosclerosis.
    Björkegren J; Silveira A; Boquist S; Tang R; Karpe F; Bond MG; de Faire U; Hamsten A
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1470-4. PubMed ID: 12231568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.